Search reports.
Biohacking Market Analysis, Share, Industry & Revenue [2031]
Get free sample report Request for Customiztion Buy Now

Biohacking Market Analysis, Share, Industry & Revenue [2031]

Segments - Global Biohacking Market by Products (Wearables, Mobile Apps, Smart Drugs, Supplements, Gene Modification Kits, Implant Chips, and Others), Applications (Research, Monitoring, Treatment, and Others), End-users (Research & Academic Institutes, Forensic Laboratories, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2023 - 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-3128 | 4.4 Rating | 79 Reviews | 175 Pages | Format : PDF Excel PPT

Report Description


Global Biohacking Market Outlook 2031:

The global biohacking market size was valued at USD 20.08 Billion in 2022 and is projected to reach USD 96.09 Billion by 2031, expanding at a CAGR of 19% during the forecast period 2023 - 2031. Biohacking refers to human augmentation, which aims at improving the performance and health of human beings through strategic interventions by using its devices or products. It involves the use of function-enhancing drugs or devices that efficiently improve the cognitive functions and memory of individuals.

Various experiments are conducted on the body by using several devices such as heart rate monitoring, stress level controls, biotechnology usage, and others. Biohacking is a method of do-it-yourself biology that can bring about a change in synthetic biology and result in developments in biotechnology, genetic engineering, and molecular biology.

Biohacking Market Outlook

  • Rising demand for smart devices and drugs to improve the cognitive function and memory of individuals are key factors driving the market growth.
  • Awareness about biohacking and health concerns among users along with the introduction of new and advanced mobile apps to track and record health graphs of patients propel the growth of the market.
  • Prevalence of chronic diseases and rise in the geriatric population who are at high risk for exposing to several diseases are positively impacted the market growth.
  • Risk of cyber security breaches, stringent government regulation towards genetic engineering experiments, and lack of funds available for medical research are major challenges that can hamper the market growth.
  • Developments in the biotechnological and genetic engineering sectors lead to the implementation of radiofrequency identification technology installed in medical devices. This is projected to offer lucrative opportunities for market expansion.
  • Outbreak of COVID-19 pandemic has propelled the medical research towards developing COVID testing kits using biohacking techniques, which is further boosting the market growth.

Scope of Biohacking Market Report

The report on the global biohacking market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Biohacking Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Products (Wearables, Mobile Apps, Smart Drugs, Supplements, Gene Modification Kits, Implant Chips, and Others), Applications (Research, Monitoring, Treatment, and Others), End-users (Research & Academic Institutes, Forensic Laboratories, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Thriveport, LLC; Apple Inc.; Moodmetric; The ODIN; Thync Global Inc.; Fitbit, Inc.; HVMN Inc.; Muse (Interaxon Inc.); TrackMyStack; and OsteoStrong

Biohacking Market Segment Insights

Increasing adoption of wearable medical devices drives the wearables segment

Based on products, the global biohacking market is segmented into wearables, mobile apps, smart drugs, supplements, gene modification kits, implant chips, and others. The wearables segment accounted for a significant market share in 2020 and is anticipated to register high growth rate during the forecast period owing to rising adoption of medical devices to track the health of the user electronically and developments in the medical sector. The implementation of smartwatches, which track the heart rate, sugar level, stress level, blood pressure, among others became extremely popular.

The penetration of smartphones and Internet of Things (IoT) along with increasing awareness about biohacking medical devices are anticipated to propel the growth of the market segment. Fitbit Inc. launched its latest technologically advanced smartphone, the Fitbit Sense in 2020 designed to track the heart rate and control stress levels using the electrodermal sensor and on-wrist skin temperature sensor.

Biohacking Market Products

Monitoring segment to hold a substantial market share during the forecast period

On the basis of applications, the market is categorized as research, monitoring, treatment, and others. The monitoring segment is projected to exhibit rapid growth during the forecast period owing to increasing demand for monitoring medical devices to measure the heart rate and other health statistics.

Additionally, rise in purchasing power of consumers is a key factor pushing to wide demand for high-end medical devices to monitor the various units of cognitive function of the human body.

Increasing demand for medical applications installed on the smartphones are expected to accelerate the growth of the segment. The research segment, however, is projected to exhibit robust growth rate in the coming years due to development of the medical research sector caused an upsurge in the research segment.

Biohacking Market Applications

Rising prevalence of chronic diseases propelled the growth of the hospitals & clinics segment

Based on end-users, the global biohacking market is classified as research & academic institutes, forensic laboratories, hospitals & clinics, pharmaceutical & biotechnology companies, and others.

The hospitals & clinics segment is expected to expand at a high CAGR during the forecast period due to the rising prevalence of chronic diseases and geriatric population.

Additionally, the wide availability of hospitals and clinics facilitate wider access for patients to get treated based on their illness or disease. Presence of skilled medical professionals and increasing demand for novel treatment options present major factors driving the market segment.

North America to retain its leading position during the forecast period

In terms of regions, the market is categorized as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a large market share in terms of revenue in 2020 and is expected to expand at a high CAGR during the forecast period owing to the presence of key players in the region and rise in biohacking awareness among consumers.

Increased R&D activities by research companies towards the integration of developed and advanced medical devices for biohacking are anticipated to further accelerate the regional market expansion. Growing support from government as well as non-government organizations towards biohacking along with advancements in the synthetic biology sector are propelling the market growth in the region.

Biohacking Market Region

Segments

By Products

  • Wearables
  • Mobile Apps
  • Smart Drugs
  • Supplements
  • Gene Modification Kits
  • Implant Chips
  • Others

By Applications

  • Research
  • Monitoring
  • Treatment
  • Others

By End-users

  • Research & Academic Institutes
  • Forensic Laboratories
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others

By Regions

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa

By Key Players

  • Thriveport, LLC
  • Apple Inc.
  • Moodmetric
  • The ODIN
  • Thync Global Inc.
  • Fitbit, Inc.
  • HVMN Inc.
  • Muse (Interaxon Inc.)
  • TrackMyStack
  • OsteoStrong

Competitive Landscape

Key players in the global biohacking market are Thriveport, LLC; Apple Inc.; Moodmetric; The ODIN; Thync Global Inc.; Fitbit, Inc.; HVMN Inc.; Muse (Interaxon Inc.); TrackMyStack; and OsteoStrong.

These players are widely engaged in various business development strategies including mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence and increase their market share.

Biohacking Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Biohacking Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Biohacking Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Biohacking Market - Supply Chain
  4.5. Global Biohacking Market Forecast
     4.5.1. Biohacking Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Biohacking Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Biohacking Market Absolute $ Opportunity
5. Global Biohacking Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Biohacking Market Size and Volume Forecast by Applications
     5.3.1. Research
     5.3.2. Monitoring
     5.3.3. Treatment
     5.3.4. Others
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Biohacking Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Biohacking Market Size and Volume Forecast by End Users
     6.3.1. Research & Academic Institutes
     6.3.2. Forensic Laboratories
     6.3.3. Hospitals & Clinics
     6.3.4. Pharmaceutical & Biotechnology Companies
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Biohacking Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Biohacking Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Biohacking Demand Share Forecast, 2019-2026
8. North America Biohacking Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Biohacking Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Biohacking Market Size and Volume Forecast by Applications
     8.4.1. Research
     8.4.2. Monitoring
     8.4.3. Treatment
     8.4.4. Others
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Biohacking Market Size and Volume Forecast by End Users
     8.7.1. Research & Academic Institutes
     8.7.2. Forensic Laboratories
     8.7.3. Hospitals & Clinics
     8.7.4. Pharmaceutical & Biotechnology Companies
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Biohacking Demand Share Forecast, 2019-2026
9. Latin America Biohacking Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Biohacking Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Biohacking Market Size and Volume Forecast by Applications
     9.4.1. Research
     9.4.2. Monitoring
     9.4.3. Treatment
     9.4.4. Others
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Biohacking Market Size and Volume Forecast by End Users
     9.7.1. Research & Academic Institutes
     9.7.2. Forensic Laboratories
     9.7.3. Hospitals & Clinics
     9.7.4. Pharmaceutical & Biotechnology Companies
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Biohacking Demand Share Forecast, 2019-2026
10. Europe Biohacking Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Biohacking Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Biohacking Market Size and Volume Forecast by Applications
     10.4.1. Research
     10.4.2. Monitoring
     10.4.3. Treatment
     10.4.4. Others
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Biohacking Market Size and Volume Forecast by End Users
     10.7.1. Research & Academic Institutes
     10.7.2. Forensic Laboratories
     10.7.3. Hospitals & Clinics
     10.7.4. Pharmaceutical & Biotechnology Companies
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Biohacking Demand Share Forecast, 2019-2026
11. Asia Pacific Biohacking Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Biohacking Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Biohacking Market Size and Volume Forecast by Applications
     11.4.1. Research
     11.4.2. Monitoring
     11.4.3. Treatment
     11.4.4. Others
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Biohacking Market Size and Volume Forecast by End Users
     11.7.1. Research & Academic Institutes
     11.7.2. Forensic Laboratories
     11.7.3. Hospitals & Clinics
     11.7.4. Pharmaceutical & Biotechnology Companies
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Biohacking Demand Share Forecast, 2019-2026
12. Middle East & Africa Biohacking Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Biohacking Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Biohacking Market Size and Volume Forecast by Applications
     12.4.1. Research
     12.4.2. Monitoring
     12.4.3. Treatment
     12.4.4. Others
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Biohacking Market Size and Volume Forecast by End Users
     12.7.1. Research & Academic Institutes
     12.7.2. Forensic Laboratories
     12.7.3. Hospitals & Clinics
     12.7.4. Pharmaceutical & Biotechnology Companies
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Biohacking Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Biohacking Market: Market Share Analysis
  13.2. Biohacking Distributors and Customers
  13.3. Biohacking Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Thriveport, LLC
     13.4.2. Apple Inc.
     13.4.3. Moodmetric
     13.4.4. The ODIN
     13.4.5. Thync Global Inc.
     13.4.6. Fitbit, Inc.
     13.4.7. HVMN Inc.
     13.4.8. Muse (Interaxon Inc.)

Methodology

Our Clients

Microsoft
Nestle SA
Siemens Healthcare
sinopec
General Electric
Deloitte
The John Holland Group
Dassault Aviation